Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.

Liu F, Xi XP, Wang H, Han YQ, Xiao F, Hu Y, He Q, Zhang L, Xiao Q, Liu L, Luo L, Li Y, Mo Y, Ma HZ.

Radiat Oncol. 2017 Jan 13;12(1):15. doi: 10.1186/s13014-016-0739-y.

2.
3.

Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.

Gai X, Wei Y, Tao H, Zhu J, Li B.

Oncotarget. 2017 Apr 18;8(16):27529-27540. doi: 10.18632/oncotarget.16770.

4.

Vicious circle of acute radiation toxicities and weight loss predicts poor prognosis for nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy.

Li G, Jiang XY, Qiu B, Shen LJ, Chen C, Xia YF.

J Cancer. 2017 Mar 7;8(5):832-838. doi: 10.7150/jca.17458. eCollection 2017.

5.

A new T staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results from a prospective multicentric clinical study.

Kang M, Zhou P, Wei T, Zhao T, Long J, Li G, Yan H, Feng G, Liu M, Zhu J, Wang R.

Am J Cancer Res. 2017 Feb 1;7(2):346-356. eCollection 2017.

6.

Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis.

Yao JJ, Yu XL, Zhang F, Zhang WJ, Zhou GQ, Tang LL, Mao YP, Chen L, Ma J, Sun Y.

Chin J Cancer. 2017 Mar 6;36(1):26. doi: 10.1186/s40880-017-0195-6.

7.

Plasma Fibrinogen Correlates with Metastasis and is Associated with Prognosis in Human Nasopharyngeal Carcinoma.

He SS, Wang Y, Yang L, Chen HY, Liang SB, Lu LX, Chen Y.

J Cancer. 2017 Feb 10;8(3):403-409. doi: 10.7150/jca.17028. eCollection 2017.

8.
9.

An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result.

Hung TM, Fan KH, Chen EY, Lin CY, Kang CJ, Huang SF, Liao CT, Ng SH, Wang HM, Chang JT.

Medicine (Baltimore). 2017 Feb;96(6):e6036. doi: 10.1097/MD.0000000000006036.

10.

A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.

Vlacich G, Stavas MJ, Pendyala P, Chen SC, Shyr Y, Cmelak AJ.

Radiat Oncol. 2017 Jan 13;12(1):13. doi: 10.1186/s13014-016-0756-x.

11.

Induction chemotherapy for the treatment of non-endemic locally advanced nasopharyngeal carcinoma.

Zhao L, Xu M, Jiang W, Pan H, Zang J, Luo S, Wang J, Zhou Y, Shi M.

Oncotarget. 2017 Jan 24;8(4):6763-6774. doi: 10.18632/oncotarget.14279.

12.

Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.

Mao YP, Tang LL, Chen L, Sun Y, Qi ZY, Zhou GQ, Liu LZ, Li L, Lin AH, Ma J.

Chin J Cancer. 2016 Dec 28;35(1):103. doi: 10.1186/s40880-016-0167-2.

13.

Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma.

Lee VH, Kwong DL, Leung TW, Choi CW, Lai V, Ng L, Lam KO, Ng SC, Sze CK, Tong CC, Ho PP, Chan WL, Wong LS, Leung DK, Chan SY, Khong PL.

Oncotarget. 2017 Jan 17;8(3):5292-5308. doi: 10.18632/oncotarget.14137.

14.

Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma.

Hong S, Zhang L.

Chin J Cancer. 2016 Dec 22;35(1):100. doi: 10.1186/s40880-016-0163-6.

16.

Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.

Zhang B, Hu Y, Xiong RH, Pan YF, Xu QL, Kong XY, Cai R, Chen QQ, Tang HY, Jiang W.

Oncotarget. 2017 Feb 21;8(8):14078-14088. doi: 10.18632/oncotarget.13285.

17.

Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study.

Luo Y, Ren J, Zhou P, Gao Y, Yang G, Lang J.

Onco Targets Ther. 2016 Nov 1;9:6775-6783. eCollection 2016.

18.

Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.

Chen JL, Huang YS, Kuo SH, Hong RL, Ko JY, Lou PJ, Wang CW.

Oncotarget. 2017 Feb 21;8(8):14068-14077. doi: 10.18632/oncotarget.12736.

19.

With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.

Liu LT, Chen QY, Tang LQ, Zhang L, Guo SS, Guo L, Mo HY, Zhao C, Guo X, Chen MY, Qian CN, Zeng MS, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ.

BMC Cancer. 2016 Oct 7;16(1):774.

20.

Intensity-modulated radiotherapy controls nasopharyngeal carcinoma distant metastasis and improves survival of patients.

Chen X, Lei H, Liang Z, Li L, Qu S, Zhu X.

Springerplus. 2016 Aug 31;5(1):1459. doi: 10.1186/s40064-016-3117-1. eCollection 2016.

Supplemental Content

Support Center